CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-28 | Ganot Ilan Director | Sale 10b5-1 | −191 | $6.59 | $1K | 17,476 |
| 2026-01-27 | Ganot Ilan Director | Option exercise 10b5-1 | +389 | 17,667 | ||
| 2026-01-27 | Ganot Ilan Director | Option exercise 10b5-1 | +3,884 | 99,297 | ||
| 2026-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −389 | 0 | ||
| 2026-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −3,884 | 0 | ||
| 2026-01-13 | Tan Kevin CFO & Treasurer | Sale 10b5-1 | −5,704 | $5.27 | $30K | 46,100 |
| 2026-01-09 | Tan Kevin CFO & Treasurer | Option exercise 10b5-1 | +11,250 | 51,804 | ||
| 2026-01-09 | Tan Kevin CFO & Treasurer | Option exercise · Restricted Stock Units 10b5-1 | −11,250 | 11,250 | ||
| 2026-01-06 | SMITH IAN F Director | Option exercise | +4,573 | 131,264 | ||
| 2026-01-06 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −4,573 | 0 | ||
| 2026-01-05 | Ganot Ilan Director | Sale | −1,053 | $5.43 | $6K | 17,278 |
| 2026-01-03 | Ganot Ilan Director | Option exercise | +2,994 | 18,331 | ||
| 2026-01-03 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −2,994 | 2,994 | ||
| 2026-01-02 | SMITH IAN F Director | Grant or award · Stock Option (Right to Buy) | +18,012 | 18,012 | ||
| 2026-01-02 | SMITH IAN F Director | Grant or award · Restricted Stock Units | +13,761 | 13,761 | ||
| 2025-12-03 | Howton David T Chief Operating Officer | Sale 10b5-1 | −4,932 | $5.11 | $25K | 32,908 |
| 2025-12-03 | Cumbo Alexander President and CEO | Sale 10b5-1 | −10,808 | $5.11 | $55K | 81,388 |
| 2025-12-03 | Hanrahan Jessie Chief Regulatory Officer | Sale 10b5-1 | −4,483 | $5.11 | $23K | 26,660 |
| 2025-12-03 | Herzich Paul Chief Technology Officer | Sale 10b5-1 | −2,701 | $5.11 | $14K | 26,622 |
| 2025-12-02 | Howton David T Chief Operating Officer | Option exercise 10b5-1 | +13,051 | 37,840 |
Page 6 of 12 · 223 trades